A new study found that disulfiram, a drug used to treat chronic alcoholism, can safely reduce anxiety levels in rodents.

As Pfizer’s antiviral Paxlovid tablets against COVID-19 roll out, the company indicated it had halted the development of the intravenous variation of the drug, PF-07304814. In other news, SaNOtize Research & Development Corp. and Glenmark Pharmaceuticals Ltd. announced that a Phase III trial of Nitric Oxide Nasal Spray (NONS) hit the primary endpoint.

A form of “virtual reality” therapy might help treat alcohol addiction, suggests a preliminary study from South Korea.  The study involved only 10 patients with alcohol dependence. But senior researcher Dr. Doug Hyun Han of Chung-Ang University Hospital in Seoul and colleagues think the approach might be promising, in part because it puts patients in […]

AUSTIN, Texas — Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind — […]